- Following the 2025 edition of La Marató de 3Cat, which raised awareness and funds for cancer research, 38 projects have now been awarded a total of more than €14 million.

- CNAG received three awards to support research projects focused on colorectal and paediatric cancers, led by our Principal Investigators Dr Marc A. Marti-Renom, Dr Anna Esteve and Dr Holger Heyn.

 

November 19, 2026. La Marató de 3Cat held its annual event to announce the research projects selected for funding through its latest edition, which raised awareness and more than €14 million for cancer research. Of the 201 proposals submitted, only 38 research projects were selected to receive support from this scientific outreach initiative. Three of these projects are led by CNAG researchers: two to advance research into colorectal cancer and another focused on paediatric cancer. In total, CNAG will receive nearly €1 million in support from La Marató. This is a very important contribution to advancing cancer prevention, diagnosis and treatment, a widespread disease that will affect one in two men and one in three women during their lifetime.

 
 
In the field of colorectal cancer, our Structural Genomics Group Leader, Dr Marc A. Marti-Renom, will coordinate a research project together with Dr Eduard Batlle (IRB Barcelona) to uncover the mechanisms underlying metastasis in this type of cancer. The project will explore how epigenetic alterations influence the behaviour of cancer cells, enabling them to adapt, colonise distant organs and become less responsive to treatment. By shedding light on these processes, the researchers hope to identify new ways to tackle metastasis and improve therapeutic outcomes.
 
 
Also focusing on colorectal cancer, Dr Holger Heyn, Single Cell Genomics Group Leader at CNAG, will collaborate with Dr Francisco Javier Ros Montañá (VHIO) to study the longitudinal single-cell and TCR profiling of tumour-reactive T cells in metastatic MSI colorectal cancer treated with immune checkpoint inhibitors.
 
 
The third project will focus on paediatric cancers, under the coordination of Dr Anna Esteve, our Functional Genomics Team Leader, together with Dr Sonia-Vanina Forcales Fernández (UB) and Dr Anna Sola Martínez (IDIBELL). Over the coming years, the team will investigate the epigenetic regulation of the NBL2 macrosatellite during development and its reactivation in paediatric cancers.
 
 
Once again, La Marató is supporting CNAG research projects, continuing a collaboration that has enabled us to advance top-notch research over the years in fields such as COVID-19 and rare diseases. This new support strengthens our contribution to cancer research, one of CNAG's strategic research areas, and reinforces our commitment to improving people's health and quality of life.